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Abstract
Background: Respiratory symptoms are common in early life and often transient. It
is difficult to identify in which children these will persist and result in asthma.
Machine learning (ML) approaches have the potential for better predictive perfor-
mance and generalisability over existing childhood asthma prediction models. This
study applied ML approaches to predict school‐age asthma (age 10) in early life
(Childhood Asthma Prediction in Early life, CAPE model) and at preschool age
(Childhood Asthma Prediction at Preschool age, CAPP model).
Methods: Clinical and environmental exposure data was collected from children
enrolled in the Isle of Wight Birth Cohort (N = 1368, ∼15% asthma prevalence).
Recursive Feature Elimination (RFE) identified an optimal subset of features pre-
dictive of school‐age asthma for each model. Seven state‐of‐the‐art ML classifica-
tion algorithms were used to develop prognostic models. Training was performed by
applying fivefold cross‐validation, imputation, and resampling. Predictive perfor-
mance was evaluated on the test set. Models were further externally validated in
the Manchester Asthma and Allergy Study (MAAS) cohort.
Results: RFE identified eight and twelve predictors for the CAPE and CAPP models,
respectively. Support Vector Machine (SVM) algorithms provided the best perfor-
mance for both the CAPE (area under the receiver operating characteristic curve,
AUC = 0.71) and CAPP (AUC = 0.82) models. Both models demonstrated good
generalisability in MAAS (CAPE 8‐year = 0.71, 11‐year = 0.71, CAPP 8‐year = 0.83,
11‐year = 0.79) and excellent sensitivity to predict a subgroup of persistent
wheezers.
Conclusion: Using ML approaches improved upon the predictive performance of
existing regression‐based models, with good generalisability and ability to rule in
asthma and predict persistent wheeze.
John W. Holloway and Faisal I. Rezwan contributed equally.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, pro-
vided the original work is properly cited.
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1 | INTRODUCTION
Childhood asthma is highly heterogeneous, with numerous factors
contributing towards its development, persistence and severity.1–3
Despite approximately 80% of asthmatic children developing symp-
toms (suchaswheeze) before the ageof six, these clinical symptomsare
neither universally present in early life among all future asthmatics nor
specific to asthma.4 With the added difficulty of making an objective
asthma diagnosis before the age of five, both under‐treatment and
over‐treatment of wheezing disorders are common in early life.5,6
The ability to predict the development of school‐age asthma can
help to identify high‐risk preschool children and distinguish them
from children whose symptoms are likely to be transient.7 Further-
more, early prediction of asthma susceptibility will be critical for the
successful implementation of potential primary prevention strategies
to reduce the risk of developing asthma.
A recent systematic review identified twenty‐one logistic
regression‐based models for predicting childhood asthma.8 However,
none of these models have been implemented into standard clinical
practice, possibly due to relatively weak predictive power, poor
generalisability and need for specialised clinical testing. The review
further proposed that regression‐based methods for predicting
childhood asthma may have been exhausted, with the identified
models offering similar predictive power to each other and being
unable to be significantly improved upon.8
Machine learning approaches have increasingly been applied to a
wide range of healthcare problems due to their ability to integrate large
quantities of heterogeneous data, handle complex interactions between
variables and identify patterns within data.9 Particularly for disease
prediction,where interactions betweenbiological variables are complex,
machine learning approaches have the potential to identify novel pre-
dictorswhichmayhavebeenpreviouslyoverlookedby regression‐based
approaches.9–11 Furthermore, application of methods to reduce model
overfitting may address the poor generalisability of existing prediction
models in independent populations. Machine learning approaches have
shown promise in predicting a variety of clinical asthma outcomes,
phenotypes and decisions,12–16 including the diagnostic or prognostic
prediction of school‐age asthma development.17–25While these studies
tend to offer improved predictive performance, none of these studies
support their findingswithexternal validationsof theirmodelsorexplain
how their “black‐box” models (where relevant) arrive at their pre-
dictions. Without these two components, machine learning models will
fail to obtain the trust of physicians and continue to be limited in their
clinical utility, regardless of the superior prediction accuracy they may
offer.26,27
This study aimed to utilise machine learning approaches to
improve upon the performance of traditional regression methods and
develop explainable and independently validated prediction models
for childhood asthma. Two prognostic prediction models, the Child-
hood Asthma Prediction in Early‐life (CAPE) and Childhood Asthma
Prediction at Preschool‐age (CAPP) models, were developed to pre-
dict school‐age asthma at 10 years, within a general population‐
based cohort, using information available from the first two years
and first four years of life, respectively.
2 | METHODS
2.1 | Developmental study population
Data was obtained from 1456 individuals from the Isle of Wight Birth
Cohort (IOWBC). Study recruitment and participant details have
been previously described28 (see supporting information S1). Ethical
approval was obtained from the Isle of Wight Local Research Ethics
Committee at recruitment and 1‐, 2‐ and 4‐year assessments (No.
05/89) and 10‐year assessments including genetic studies (No. 18/
98). Prior to participation in the study at each follow‐up, written
informed consent was obtained from parents of children, and assent
from children (where applicable). This study received approval from
the University of Southampton Faculty of Medicine ethics committee
(ERGO number 46033.R1).
2.2 | Prediction outcome
School‐age asthma, evaluated at age 10, was defined as “a doctor
diagnosis of asthma ever and at least one episode of wheezing or use
of asthma medication in the last 12 months”. Only individuals with a
reported asthma status at the 10‐year follow‐up were included in the
analyses (n = 1368).
2.3 | Candidate predictors
Fifty‐four candidate predictors previously reported to be associated
with childhood asthma, and forwhich datawas available in the IOWBC,
were identified (Table E1). Candidate predictors included data on
subject demographics, lifestyle, clinical symptoms of allergy and
asthma and environmental exposures collected across three time
points: at birth (prenatal and perinatal data), early life (combined
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exposure at either the 1‐year or the 2‐year follow‐ups) and at pre-
school age (4‐year follow‐up).
2.4 | Model development
All stages of model development were performed independently for
the CAPE and CAPP models (Figure 1).
2.5 | Feature selection
For each model, feature selection was performed on the complete
dataset for all available candidate predictors (without any missing
values) using Recursive Feature Elimination (RFE) with a random
forest algorithm, using fivefold cross‐validation (see supporting -
information S1).
2.6 | Model construction and optimisation
To identify the best classification algorithm, seven machine learning
classifiers were implemented: two support vector machines (SVM)
(linear and radial basis (RBF) kernel functions), decision tree, random
forest, naive Bayes, multilayer perceptron, and K‐Nearest Neigh-
bours (see supporting information S1).
Each machine learning algorithm was initially trained and eval-
uated on the subset of individuals who had complete data for the
F I GUR E 1 Workflow for the development and validation of asthma prediction models using machine learning approaches. Model
development in the Isle of Wight Birth Cohort (IOWBC) was performed independently in for the construction of the CAPE and CAPP tools.
(A) Feature selection was performed using only individuals with complete data for all candidate predictors. (B, C) Seven machine learning
classifiers (two support vector machines with different kernel functions (linear and radial basis function), naïve Bayes classifier, decision tree,
multilayer perceptron, random forest and K‐nearest neighbours) were developed. Models were developed using complete data for the subset of
features identified from feature selection (B), and subsequently redeveloped using optimised training datasets (C). Training dataset optimisation
consisted of the step‐wise application of imputation and resampling (oversampling using ADASYN and random undersampling) to the entire
IOWBCdataset not allocated to the test dataset, including thosewithmissingpredictor data (CAPE:n=1113;CAPP:n=1185). (D)ThebestCAPE
andCAPPmodelswere selected based on performance in the test set. (E) Selectedmodelswere externally validated to predict school‐age asthma
at ages 8 and 11 years in an independent population (Manchester Asthma and Allergy Study, MAAS). †The performance of the best CAPE model
wasdevelopedon thecomplete trainingdataset, undersampled tobalance class proportions (n=136). ThebestCAPPmodelwasdevelopedon the
complete training dataset, with cases oversampled by 300% and controls undersampled to balance class proportions (n = 408)
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predictors selected through RFE. The dataset was split (ratio of 2:1,
preserving class proportions) into a training and holdout test set for
model development and validation, respectively (Figure 1). Within a
fivefold cross‐validation, the hyperparameters for each model were
tuned using a grid search, optimising for its balanced accuracy (see
supporting information S1, Table E2).
The training dataset was then optimised to further improve the
performance of the classification algorithms. Multiple imputation us-
ing Multivariate Imputation by Chain Equations (MICE),29 over-
sampling using an adaptive synthetic sampling approach (ADASYN),30
and random under‐sampling were implemented in a stepwise
approach to address the degree of missing data and class imbalance in
the training set (see supporting information S1). The seven algorithms
were then redeveloped, with hyperparameters retuned, on each
optimised training set to identify the best asthma prediction model(s)
and tested on the same holdout test set (Figure 1).
The best CAPE and CAPP models were selected based on their
discriminative performance on the test set using the area under the
receiver operating characteristics curve (AUC). Sensitivity, specificity,
positive and negative predictive values (PPV and NPV), positive and
negative likelihood ratios (LR+ and LR−), balanced accuracy, F1‐
score and Brier score were reported at the optimal threshold that
maximized the Youden's Index, with 2000 bootstrap samples used to
calculate 95% confidence intervals for the performance measures.
2.7 | External validation
The best performing models were validated in the Manchester
Asthma and Allergy Study (MAAS) cohort31 to predict school‐age
asthma at ages eight and eleven (Figure 1, see supporting informa-
tion S1). Data extracted from MAAS was closely matched to maxi-
mise the similarity of predictor and outcome definitions used in the
development cohort (Table E3).
2.8 | Sensitivity analyses
Sensitivity analyses were conducted to comprehensively evaluate the
developed models, including evaluations of (i) their generalisability in
high risk subgroups; (ii) their robustness to predict an alternative
definition of school‐age asthma; (iii) the resolution of the predictions
to distinguish between individuals presenting with distinct wheeze
phenotypes throughout childhood and adolescence; and (iv) their
performance compared to similar regression‐based models (see
supporting information S1).
2.9 | Explaining the ‘black‐box’ models
SHapley Additive exPlanations (SHAP)32 were used to evaluate
feature importance and provide global explanations for how pre-
dictions were made by the CAPE and CAPP models (see
supporting information S1). Examples of how SHAP can be used
locally to explain individual predictions were also provided.
3 | RESULTS
In the IOWBC, 1368 enrolled participants had a defined asthma
outcome at age 10, of whom 201 (14.69%) were asthmatic. Baseline
characteristics between individuals with complete data were largely
comparable with the full IOWBC dataset (Table E4).
3.1 | Childhood Asthma Prediction in Early‐life
(CAPE) model
Complete data on all 39 predictors collected by age two was avail-
able for 490 individuals. RFE identified a subset of eight predictors
for inclusion in the CAPE model, with an average balanced accuracy
of 64.49%. Figure 2A details the feature importance, direction, and
magnitude of asthma risk for each selected predictor based on SHAP.
Complete data for these eight predictors was available for 765 in-
dividuals; 510 (68 asthmatics) and 255 (34 asthmatics) individuals
were allocated to the initial training and test sets, respectively. An
SVM classifier (RBF kernel) was the best performing classification
algorithm for the CAPE model (AUC = 0.71, Brier score = 0.21)
(Table 1A).
3.2 | External validation of the CAPE model
To predict the development of asthma at the 8‐year and 11‐year
time‐points in MAAS, complete data on the eight CAPE predictors
was available for 322 and 299 individuals, respectively. Table E5
compares the distribution of predictors in the IOWBC and MAAS.
The CAPE model demonstrated moderate generalisability, maintain-
ing an AUC = 0.71 at both 8 and 11 years (Table 1A; Figure 3),
despite slight reductions in PPV. In the high‐risk subgroups, despite a
3%–4% increase in PPV, overall predictive performance decreased
(Table 1A).
3.3 | Childhood Asthma Prediction at Preschool‐age
(CAPP) model
For the CAPP model, 373 individuals had complete data for all 54
candidate predictors available by age four. RFE identified an optimal
subset of 12 predictors for inclusion in the model, with an average
balanced accuracy of 74.93% (Figure 2B). Complete data for these 12
predictors was available for 548 individuals, of whom 365 (51 asth-
matics) and 183 (25 asthmatics) individuals were assigned to the
initial training and test sets, respectively. The best performing clas-
sification algorithm for the CAPP model was an SVM (linear kernel)
classifier (AUC = 0.82, Brier score = 0.18) (Table 1B).
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3.4 | External validation of the CAPP model
For validation of the CAPP model in MAAS at the 8‐year and 11‐year
time‐points, complete data for the 12 CAPP predictors was available
for 282 and 267 individuals, respectively. The model demonstrated
good generalisability to predict asthma at both 8 and 11 years
(AUC = 0.83 and 0.79, respectively) in the unselected MAAS sub-
group (Table 1B; Figure 3). PPV also remained comparable in MAAS
(PPV = 0.45 and 0.41, respectively), with further improvements re-
ported in the high‐risk subgroup validations at both time‐points
(Table 1B).
3.5 | Sensitivity analysis
The CAPE and CAPP models were robust in correctly predicting non‐
asthmatics using the alternative asthma definition (similar NPV).
However, neither model was robust in predicting asthmatics, with an
increase in false positive predictions reducing the PPV by approxi-
mately 50% for both models, likely due to disagreement between the
original and modified asthma definitions (Table E6; Figure E1).
Furthermore, both models showed excellent power to predict a
persistent wheeze phenotype, with 100% and 90% of individuals with
persistent wheeze offered a positive prediction by the CAPE and
F I GUR E 2 SHAP feature explanations for the CAPE and CAPP models. The SHAP summary plots describe the contribution of the features
selected during RFE for inclusion in the CAPE (A) and CAPP models (B). Predictors are listed in descending order of their SHAP value. The
higher the SHAP value, the larger its contribution on model predictions. Each dot in each predictor row corresponds to a separate individual.
The placing of the dot along the x‐axis represents the contribution of the predictor in the individual's asthma prediction. The colour of the dot
refers to the feature value, with higher values in red and lower values in blue. For example, early life cough offers the highest contribution to
the random forest model, with higher values (presence of early life cough) having a positive contribution towards a prediction of asthma. The
absence of early life cough (blue dots) reduces the impact/contribution of the model delivering a prediction of asthma
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CAPP models in the IOWBC, respectively (90% and 57% in MAAS,
respectively) (Figure 4).
3.6 | Comparison with regression methods
Both the CAPE and CAPP models outperformed their equivalent
logistic regression models (Table E7; Figure 3). There was a sub-
stantial decline in predictive performance of the CAPE‐logistic
regression model (AUC = 0.59 vs. 0.71), with predictions being no
better than chance in MAAS at 8 and 11 years (AUC = 0.47 and 0.49,
respectively). Predictive power of the CAPP‐logistic regression
model was also lower compared to the CAPP‐machine learning model
(AUC = 0.76 vs. 0.82, PPV = 0.33 vs. 0.47).
Whilst the benchmark regression‐based model for the CAPE
model (Persistent Asthma Predictive Score)33 was unable to be
replicated due to lack of data on key predictors in the IOWBC, the
model comparable with the CAPP model, PARS (Paediatric Asthma
Risk Score),34 was replicated in the IOWBC and MAAS (AUC in
IOWBC = 0.77, MAAS 8‐year = 0.79, MAAS 11‐year = 0.76). Among
individuals with predictions available for both the CAPP and PARS
models, positive net reclassification indices show that the proportion
of reclassifications made by the CAPP model offered equal, if not
greater, accuracy to predict future asthmatics than PARS in both the
IOWBC (Table 2) and MAAS (Table E8).
3.7 | Explaining the “black‐box” models
Based on SHAP, only a subset of predictors included in each model
were shown to have a major contribution on the predictions—early
life cough and wheeze for the CAPE model and preschool cough,
atopy and polysensitisation for the CAPP model (Figure E2). The
contributions of these predictors were consistent with explanations
of individual predictions (Figure E3). Redevelopment of the models
including only these highly contributing predictors showed similar
performance for the CAPP model but a 10% fall in AUC for the CAPE
model (Figure E4).
4 | DISCUSSION
4.1 | Summary of findings
Two models, predicting school‐age asthma at age 10 within a general
population, were developed using machine learning classification
methods. The CAPE model uses a RBF SVM classifier and eight
predictors to predict school‐age asthma in early life. The CAPP model
uses a linear SVM classifier and twelve predictors available by age
four. Both machine learning models offered superior predictive po-
wer and generalisability upon external validation compared to
equivalent models developed using logistic regression methods as
well as existing regression‐based models. Whilst the primary pre-
diction outcome was school‐age asthma, both models demonstrated
excellent sensitivity in predicting individuals likely to experience
persistentwheeze throughout childhood.
4.2 | Comparisons with existing models
To date, twenty‐one regression‐based prediction models have been
developed for childhood asthma (reviewed in Kothalawala et al.8), of
which only six have been externally validated (Table E9). A recent
systematic review further identified 10 studies that developed pre-
diction models for childhood asthma using machine learning ap-
proaches, but only eight specifically predicted school‐age asthma
(5–14 years).26 Another study directly compared the performance of
a current regression‐based asthma prediction model, PARS, with a
conditional inference tree‐based decision rule model using the same
predictors.25 However, none of these studies externally validated the
machine learning models they proposed.
Similar to the CAPE and CAPP models, most published asthma
prediction models are very good at ruling out asthma rather than
ruling in asthma, resulting partly from low power due to low asthma
prevalence.8 Even if existing models offer good PPV, this often de-
grades upon validation.8 Indeed, despite having similar asthma
prevalence to existing studies in the original training set, the machine
learning‐based CAPP model offered a 30% improvement in
F I GUR E 3 Discriminative performance of the CAPE and CAPP machine learning models. The ROC curves compare the discriminative
performance of the CAPE and CAPP machine learning models, their equivalent logistic regression models and the PARS model in the IOWBC
at age 10 (A) and upon validation in MAAS at age 8 years (B) and 11 years (C)
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sensitivity compared to the only model suggested in asthma guide-
lines described to date (sensitivity: CAPP = 0.72 vs. loose Asthma
Predictive Index = 0.42)35 and further 10% improvement in PPV
compared to its benchmark model, PARS. This is consistent with
Owora et al.‘s novel tree‐based model offering better predictive
performance compared to an equivalent regression‐based PARS
model (AUC = 0.85 vs. 0.71).25 Many of the other machine learning
models also demonstrated greater performance to predict asthma
than existing regression‐based models.26 However, with low sample
sizes and indications of overfitting in many of these studies, the lack
of external validation renders it impossible to evaluate any superior
performance offered by these models, especially since they were all
developed in high‐risk populations. Importantly, our CAPP machine
learning model was more generalisable and retained its positive
predictive power upon replication compared to its equivalent logistic
regression model. Furthermore, reclassification tables comparing the
CAPP and PARS models were suggestive of the CAPP model pre-
dicting future asthmatics more accurately than PARS, with a greater
proportion of correct reclassifications than incorrect reclassification
made by the CAPP model in both the IOWBC and MAAS. However,
this needs to be confirmed within a larger cohort. The moderate but
limited predictive power of the CAPE model compared to the CAPP
F I GUR E 4 CAPE and CAPP model predictions and corresponding wheeze trajectories. The proportion of individuals corresponding to
their most probable wheeze phenotype is presented for those predicted to be asthmatic or non‐asthmatic by the CAPE and CAPP models in
the IOWBC (A, B) and MAAS (C, D)
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model was unsurprising given the known difficulty of predicting the
future development of childhood asthma using data from the first few
years of life.36
4.3 | Predictor selection and availability
Both the CAPE and CAPP models include data collected across
multiple time‐points (Figures E5 and E6). Given the variable nature of
asthma development and risk throughout early childhood, the
consideration of predictors across multiple time‐points allowed for
the identification of novel combinations of predictors that together
improved the ability of the models to predict asthma. Whilst data
collected across multiple time‐points may hinder the utility of the
models, the selected predictors are all typically reported during
routine health visits or tracked in child health records. Only the
predictors of atopy and polysensitisation, which require a skin prick
test (SPT), may restrict the applicability of the CAPP model in pri-
mary care. However, as these predictors are well‐established in the
literature, were shown to make large contributions to the predictions
(Figure E2), and resulted in a 10% reduction in AUC when excluded
from the model (Table E10), the predictive benefit offered by the
inclusion of sensitisation was deemed to outweigh the potential
reduction in applicability.
Of the predictors selected for inclusion in the two models, some
were well‐established risk factors with a clear inferred direction of
asthma risk (Figure 2). Others were predictors which have not pre-
viously been used in childhood asthma prediction models (maternal
age at the time of the child's birth, age of solid food introduction and
total breastfeeding duration) and offer a less clear direction of
asthma risk. The selection of these novel predictors, over others that
have a more established biological relevance in the literature (such as
parental asthma, eczema or allergic rhinitis), may be cautiously
accepted by the clinical community. However, RFE identifies the
subset of features that collectively offer the best predictive accuracy
rather than devising a comprehensive list of childhood asthma risk
factors, which may be biologically sound but lacking in predictive
power.37 In fact, the predictors of wheeze and cough were among
those repeatedly included in the majority of machine learning models
identified to date.26 The predictors of atopy, polysensitisation and
wheeze were also included in Owora et al.‘s machine learning model,
however the predictors were taken from the PARS model rather than
being identified from an independent feature selection.25 It is also
important to acknowledge the possibility that the selection of these
novel predictors may stem from an inherent bias of the random
forest algorithm to assign greater importance to features which are
continuous or which have a large number of categories.38 However,
as the CAPE and CAPP models developed using these selected pre-
dictors demonstrated improved performance against existing pre-
diction models, any bias stemming from the feature selection process
did not appear to limit the inclusion of features that were truly
predictive of school‐age asthma.
4.4 | Prediction generalisability, robustness and
resolution
In the unselected MAAS cohort, the CAPE and CAPP models showed
moderate to good generalisability to predict asthma across school
ages, despite the marginal decline in the PPV of the CAPE model.
TAB L E 2 Reclassification table showing changes in prediction categorisation between the PARS and CAPP model
Predicted risk (CAPP model) Reclassified by CAPP (%)
Predicted risk (PARS model) No asthma Asthma Total Increased risk Decreased risk Correctly reclassified NRI
No asthma at age 10 (n = 149)
No asthma 130 9b 139
Asthma 1a 9 10 9 (6%) 1 (<1%) 1 (<1%) −0.05
Total 131 18 149
Asthma at age 10 (n = 25)
No asthma 7 8a 15
Asthma 0b 10 10 8 (32%) 00 (0%) 8 (32%) 0.32
Total 7 18 25
Total 17 1 9
Note: Reclassification table comparing the change in individual asthma predictions with the CAPP model instead of the PARS model (reference model).
For the PARS model, categorisations of predictions as asthmatic and non‐asthmatic was based on the optimal threshold (cutoff = 7) as defined in their
original publication. Results are presented separately for individuals who were asthmatic and non‐asthmatic at age 10. Values in bold identify the
number of individuals with disagreement in their asthma predictions made by the CAPP and PARS models. NRI = net reclassification index is given
separately for true asthmatics and non‐asthmatics.
aReclassified into a more appropriate risk group by the CAPP model with respect to classifications made by the PARS model.
bReclassified into a less appropriate risk group by the CAPP model with respect to classifications made by the PARS model.
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Validation in high‐risk MAAS subgroups showed the PPV of both
models to increase with the number of allergic parents, suggesting
that confidence in ruling in asthma improves in high‐risk groups; but
replication in a larger study population is required.
The lack of a clear definition for asthma is an unavoidable limi-
tation in epidemiological studies.39 The asthma definition used in this
study aimed to account for children with a clinical indication of
asthma (physician diagnosed) who were actively symptomatic, but
also those potentially asymptomatic at the time of assessment due to
the use of symptom relieving medications. Whilst both models were
robust in predicting non‐asthmatics using an alternative asthma
definition of wheeze and bronchial hyper‐responsiveness (BHR), they
had reduced power to predict true asthmatics (∼50% decline in PPV).
The latter may be explained by objective tests, such as spirometry
and BHR, being influenced by treatment; potential asthmatics on
controller medications, whom the models are trained to identify as
asthmatic, may be considered as non‐asthmatic with the alternative
definition, resulting in greater false positive predictions.
As the aim of this study was to compare whether machine
learning approaches could improve upon existing regression‐based
models that predict childhood asthma, the primary prediction
outcome for this study was restricted to school‐age asthma rather
than predicting asthma phenotypes. However, acknowledging the
importance of exploring specific sub‐phenotypes of asthma, the res-
olution of the machine learning models to predict an individual's
future wheeze trajectory was explored. Notably, both the CAPE and
CAPP models showed excellent sensitivity to predict individuals with
a persistent wheeze phenotype; these individuals would likely benefit
from early primary or secondary asthma prevention/management.
To promote the clinical use of complex machine learning
methods, studies must address the major hurdle of model inter-
pretability. This study demonstrates how tools such as SHAP values32
can be used to unravel explanations of complex black‐box machine
learning algorithms that have shown to improve the accuracy of
childhood asthma predictions.
4.5 | Strengths and limitations
This study had a number of strengths. First, each model was devel-
oped to make timely predictions to identify future asthmatics within
a general population, rather than among those already considered at
high‐risk (mainly those experiencing wheeze or with a familial history
of asthma/allergy). Second, by utilising machine learning methods,
novel predictor subsets for school‐age asthma were identified and
the developed models offered improved predictive performance over
current regression‐based methods. Third, to our knowledge, this is
the first study to externally validate asthma prediction models
developed using machine learning approaches. The models demon-
strated good generalisability to predict school‐age asthma across
multiple time‐points, without degrading the predictive power to rule
in asthma (particularly with the CAPP model). Fourth, the two models
displayed excellent sensitivity to predict a subgroup of individuals
with persistent wheeze. Finally, this study was able to use SHAP to
address one of the key issues preventing the uptake of machine
learning methods in clinical practice—the inability to interpret the
models and explain the individual predictions made.
However, this study was limited by both model development and
validation being conducted in predominantly Caucasian populations.
Machine learning also requires large datasets—the introduction of
more data would undoubtedly improve the performance of the ma-
chine learning models and offer more precise performance estimates
with smaller confidence intervals. To retain a sample size appropriate
for machine learning, feature selection was conducted before per-
forming a train‐test split. This decision could have resulted in infor-
mation leakage, potentially biasing the performance seen in the
IOWBC test sets. To mitigate any bias, external replication was used
to evaluate the models; as performance in MAAS was similar to the
IOWBC, data leakage was not deemed a significant problem. Finally,
whilst genomic data was available in the IOWBC, only clinical and
environmental predictors were considered in order to maximize the
clinical applicability of the models. It is possible that the consider-
ation of genomic predictors might significantly improve childhood
asthma predictions further22,40; however, the aim of this study was to
explore whether machine learning methods could surpass the pre-
dictive ceiling that existing logistic regression methods appeared to
be limited to. Hence, to provide a fair comparison with existing
regression‐based models, such asthma biomarkers were not incor-
porated into this study.
5 | CONCLUSION AND FUTURE WORK
Using machine learning, the CAPE and CAPP models were able to
surpass the predictive performance of similar models developed us-
ing traditional logistic regression‐based methods. Both models were
generalisable in an independent population, with the CAPP model
also demonstrating superior predictive power to rule in true asth-
matics compared to its benchmark model (and was retained upon
validation). Future application of these models could include the
development of a personalised tool/app capable of providing expla-
nations of which predictors contributed to an individual's predicted
probability of developing asthma. Both models also demonstrated
excellent sensitivity to predict a subgroup of persistent wheezers.
Therefore, rather than developing an all‐encompassing asthma pre-
diction tool, further research into predicting specific ‘asthmas’ using
machine learning approaches may offer greater predictive insight and
clinical utility. Finally, continued exploration of machine learning
approaches and the identification and integration of novel bio-
markers is warranted to further improve the power to predict future
childhood asthma.
ACKNOWLEDGMENTS
The authors would like to acknowledge the help of all the staff at the
David Hide Asthma and Allergy Research Centre in undertaking the
assessments of the Isle of Wight Birth Cohort. The authors would
10 of 12 - KOTHALAWALA ET AL.
also like to thank the IOWBC and MAAS study participants and their
parents for their continued support and enthusiasm. Recruitment
and initial assessment for the first 4 yearsof age for the IOWBC was
supported by the Isle of Wight Health Authority. The 10‐year follow‐
up of the IOWBC was funded by the National Asthma Campaign, UK
(Grant No 364). MAAS was supported by the Asthma UK Grants No
301 (1995–1998), No 362 (1998–2001), No 01/012 (2001–2004),
No 04/014 (2004–2007), BMA James Trust (2005) and The JP
Moulton Charitable Foundation (2004‐current), The North west
Lung Centre Charity (1997‐current) and the Medical Research
Council (MRC) G0601361 (2007–2012), MR/K002449/1 (2013–
2014) and MR/L012693/1 (2014–2018). UNICORN (Unified Cohorts
Research Network): Disaggregating asthma MR/S025340/1. The
authors would also like to acknowledge the use of the IRIDIS High
Performance Computing Facility, and associated support services at
the University of Southampton, in the completion of this work.
This work was supported by the National Institute for Health
Research through the NIHR Southampton Biomedical Research
Centre and a University of Southampton Presidential Research Stu-
dentship. Replication analysis in MAAS was supported by the Medical
Research Council as part of UNICORN (Unified Cohorts Research
Network): Disaggregating asthma MR/S025340/1. Angela Simpson
and Clare Murray are supported by the NIHR Manchester Biomedical
Research Centre.
CONFLICT OF INTEREST
The authors have no funding relationships or conflicts of interest
related to this article to disclose.
AUTHOR CONTRIBUTIONS
Conceptualization and design: Dilini M. Kothalawala, S. Hasan Arshad,
Faisal I. Rezwan and John W. Holloway. Data acquisition: John W.
Holloway, Angela Simpson, Adnan Custovic, S. Hasan Arshad and
STELAR/UNICORN investigators. Analysis and interpretation: Dilini M.
Kothalawala. Manuscript draft: Dilini M. Kothalawala. Manuscript
revision and final approval: all authors.
STELAR/UNICORN INVESTIGATORS
Graham C Roberts, Human Development and Health, Faculty of
Medicine, University of Southampton, David Hide Asthma and Al-
lergy Research Centre, Isle of Wight and NIHR Southampton
Biomedical Research Centre, University Hospitals Southampton NHS
Foundation Trust, Southampton, UK.
Steve W Turner, Child Health, University of Aberdeen, Aberdeen,
UK.
Raquel Granell, MRC Integrative Epidemiology Unit, Population
Health Sciences, Bristol Medical School, University of Bristol, UK.
Sadia Haider, National Heart and Lung Institute, Imperial College
London, UK.
Sara Fontanella, National Heart and Lung Institute, Imperial
College London, UK.
Paul Cullinan, National Heart and Lung Institute, Imperial Col-
lege London, UK.
ORCID
Dilini M. Kothalawala https://orcid.org/0000-0002-5804-0457
Clare S. Murray https://orcid.org/0000-0002-8961-8055
Angela Simpson https://orcid.org/0000-0003-2733-6666
Adnan Custovic https://orcid.org/0000-0001-5218-7071
William J. Tapper https://orcid.org/0000-0002-5896-1889
S. Hasan Arshad https://orcid.org/0000-0001-5988-235X
John W. Holloway https://orcid.org/0000-0001-9998-0464
Faisal I. Rezwan https://orcid.org/0000-0001-9921-222X
REFERENCES
1. Akdis CA, Agache I. Global Atlas of Asthma. European Academy of
Allergy and Clinical Immunology; 2013.
2. Licari A, Castagnoli R, Brambilla I, et al. Asthma endotyping and
biomarkers in childhood asthma. Pediatr Allergy Immunol Pulmonol.
2018;31:44‐55.
3. Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining air-
ways diseases. Lancet. 2018;391:350‐400.
4. Ullmann N, Mirra V, Di Marco A, et al. Asthma: differential diagnosis
and comorbidities. Front Pediatr. 2018;6:276.
5. Isabella Annesi‐Maesano CS, Caillaud D, de Blay F, Lavaud F,
Charpin D, Raherisson C. Factors related to under‐diagnosis and
undertreatment of childhood asthma in metropolitan France. Multi-
discip Respir Med. 2012;7.
6. Bush A, Fleming L, Saglani S. Severe asthma in children. Respirology.
2017;22:886‐897.
7. Martinez FD, Taussig LM, Holberg CJ, Halonen M, Morgan WJ.
Asthma and wheezing in the first six years of life. The Group Health
Medical Associates. N Engl J Med. 1995;332:133‐138.
8. Kothalawala DM, Kadalayil L, Weiss VBN, et al. Prediction models
for childhood asthma: a systematic review. Pediatr Allergy Immunol.
2020;31:616‐627.
9. James G, Witten D, Hastie T, Tibshiran R. An Introduction to Statistical
Learning. 1st ed. Springer‐Verlag; 2013.
10. Singal AG, Mukherjee A, Elmunzer BJ, et al. Machine learning algo-
rithms outperform conventional regression models in predicting
development of hepatocellular carcinoma. Am J Gastroenterol.
2013;108:1723‐1730.
11. Waljee AK, Higgins PD, Singal AG. A primer on predictive models.
Clin Transl Gastroenterol. 2014;5:e44.
12. Prosperi MC, Marinho S, Simpson A, Custovic A, Buchan IE. Pre-
dicting phenotypes of asthma and eczema with machine learning.
BMC Med Genomics. 2014;7(Suppl 1):S7.
13. Finkelstein J, Jeong IC. Machine learning approaches to personalize
early prediction of asthma exacerbations. Ann N Y Acad Sci. 2017;
1387:153‐165.
14. Goto T, Camargo CA, Jr., Faridi MK, Yun BJ, Hasegawa K. Machine
learning approaches for predicting disposition of asthma and
COPD exacerbations in the ED. Am J Emerg Med. 2018;36:
1650‐1654.
15. Patel SJ, Chamberlain DB, Chamberlain JM. A machine learning
approach to predicting need for hospitalization for pediatric asthma
exacerbation at the time of emergency department triage. Acad
Emerg Med. 2018;25:1463‐70.
16. Saglani S, Custovic A. Childhood asthma: advances using machine
learning and mechanistic studies. Am J Respir Crit Care Med. 2018;
199:414‐422.
17. Chatzimichail EA, Rigas AG, Paraskakis EN. An artificial intelligence
technique for the prediction of persistent asthma in children. In
Proceedings of the 10th IEEE International Conference on Information
Technology and Applications in Biomedicine; 2010:1‐4.
18. Chatzimichail E, Paraskakis E, Rigas A. An evolutionary two‐
objective genetic algorithm for asthma prediction. In 2013 UKSim
KOTHALAWALA ET AL. - 11 of 12
15th International Conference on Computer Modelling and Simulation;
2013:90‐94.
19. Chatzimichail E, Paraskakis E, Sitzimi M, Rigas A. An intelligent
system approach for asthma prediction in symptomatic preschool
children. Computd Math Methods Med. 2013;2013:240182.
20. Chatzimichail E, Paraskakis E, Rigas A. Predicting asthma outcome
using partial least square regression and artificial neural networks.
Adv Artif Intell. 2013:1‐7.
21. Krautenbacher N, Flach N, Böck A, et al. A strategy for high‐
dimensional multivariable analysis classifies childhood asthma phe-
notypes from genetic, immunological, and environmental factors.
Allergy. 2019.
22. Fehrenbach H, Smolinska A, Klaassen EMM, et al. Profiling of volatile
organic compounds in exhaled breath as a strategy to find early
predictive signatures of asthma in children. PLoS One. 2014;9.
23. AlSaad R, Malluhi Q, Janahi I, Boughorbel S. Interpreting patient‐
specific risk prediction using contextual decomposition of
BiLSTMs: application to children with asthma. BMC Med Inform Decis
Mak. 2019;19:214.
24. Bose S, Kenyon CC, Masino AJ. Personalized prediction of early
childhood asthma persistence: a machine learning approach. PLoS
One. 2021;16:e0247784.
25. Owora AH, Tepper RS, Ramsey CD, Becker AB. Decision tree‐based
rules outperform risk scores for childhood asthma prognosis. Pediatr
Allergy Immunol. 2021.
26. Patel D, Hall GL, Broadhurst D, Smith A, Schultz A, Foong RE. Does
machine learning have a role in the prediction of asthma in children?
Paediatr Respir Rev. 2021.
27. Ahmad MA, Teredesai A, Eckert C. Interpretable machine learning in
healthcare. In 2018 IEEE International Conference on Healthcare
Informatics (ICHI); 2018:447.
28. Arshad SH, Holloway JW, Karmaus W, et al. Cohort profile: the Isle
of Wight Whole Population Birth Cohort (IOWBC). Int J Epidemiol.
2018;47:1043‐4i.
29. Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by
chained equations: what is it and how does it work? Int J Methods
Psychiatr Res. 2011;20:40‐49.
30. He H, Garcia EA, Adasyn SL. Adaptive synthetic sampling approach
for imbalanced learning. In IEEE International Joint Conference on
Neural Networks (IEEE World Congress on Computational Intelligence),
Hong Kong; 2008:1322‐1328.
31. Custovic A, Simpson BM, Murray CS, Lowe L, Woodcock A. The
National Asthma Campaign Manchester Asthma and Allergy Study.
Pediatr Allergy Immunol. 2002;13:32‐37.
32. Lundberg S, Lee S‐I. A Unified Approach to Interpreting Model Pre-
dictions. arXiv preprint. arXiv:170507874 2017.
33. Vial Dupuy A, Amat F, Pereira B, Labbe A, Just J. A simple tool to
identify infants at high risk of mild to severe childhood asthma: the
Persistent Asthma Predictive Score. J Asthma. 2011;48:1015‐1021.
34. Biagini Myers JM, Schauberger E, He H, et al. A Pediatric Asthma
Risk Score to better predict asthma development in young children.
J Allergy Clin Immunol. 2018;143:1803‐1810e2.
35. Castro‐Rodríguez JAHC, Wright AL, Martinez FD. A clinical index to
define risk of asthma in young children with recurrent wheezing. Am
J Respir Crit Care Med. 2000;162:1403‐1406.
36. Global Initiative for Asthma. Global Strategy for Asthma Management
and Prevention; 2018.
37. Isabelle Guyon JW, Barnhill S. Gene selection for cancer classifica-
tion using support vector machines. Mach Learn. 2002;46:389‐422.
38. Strobl C, Boulesteix A‐L, Zeileis A, Hothorn T. Bias in random forest
variable importance measures: illustrations, sources and a solution.
BMC Bioinf. 2007;8.
39. Van Wonderen KE, Van Der Mark LB, Mohrs J, Bindels PJ, Van Aal-
derenWM, Ter Riet G. Different definitions in childhood asthma: how
dependable is the dependent variable? Eur Respir J. 2010;36:48‐56.
40. Klaassen EM, van de Kant KD, Jobsis Q, et al. Exhaled biomarkers
and gene expression at preschool age improve asthma prediction at
6 years of age. Am J Respir Crit Care Med. 2015;191:201‐207.
SUPPORTING INFORMATION
Additional supporting information may be found in the online version
of the article at the publisher's website.
How to cite this article: Kothalawala DM, Murray CS,
Simpson A, et al. Development of childhood asthma prediction
models using machine learning approaches. Clin Transl Allergy.
2021;e12076. https://doi.org/10.1002/clt2.12076
12 of 12 - KOTHALAWALA ET AL.
